This paper presents a clinical situation in which a Technetium 99m sestamibi myocardial perfusion scintigraphy (MPS) with dipyridamole was used as part of the preoperative evaluation in a 15 year old female with Tetralogy of Fallot. MPS revealed no evident inducible myocardial ischemia, depressed LV wall function and RVH but with good RV function. There are many different techniques for imaging and studying patients with Tetralogy of Fallot (TOF). Echocardiography, ventriculography and invasive angiography remain the mainstay in its evaluation. However, the presence of coronary anomalies in these patients is very common and has negative effect on myocardial perfusion, either preoperatively or postoperatively. Hence, MPS plays an essential role in providing complete assessment in this group of patients.

Human ; Female ; Adolescent ; Angiography ; Cerebral Ventriculography ; Dipyridamole ; Echocardiography ; Heart Defects, Congenital ; Myocardial Ischemia ; Perfusion Imaging ; Technetium Tc 99m Sestamibi ; Tetralogy Of Fallot ; Tomography, X-ray Computed ; ; ; ;